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Exosomes are thought to be released by all cells in the body and to
be involved in intercellular communication. We tested whether
neural exosomes can regulate the development of neural circuits.
We show that exosome treatment increases proliferation in de-
veloping neural cultures and in vivo in dentate gyrus of P4 mouse
brain. We compared the protein cargo and signaling bioactivity of
exosomes released by hiPSC-derived neural cultures lackingMECP2, a
model of the neurodevelopmental disorder Rett syndrome, with
exosomes released by isogenic rescue control neural cultures.
Quantitative proteomic analysis indicates that control exosomes
contain multiple functional signaling networks known to be impor-
tant for neuronal circuit development. Treating MECP2-knockdown
human primary neural cultures with control exosomes rescues
deficits in neuronal proliferation, differentiation, synaptogenesis,
and synchronized firing, whereas exosomes from MECP2-deficient
hiPSC neural cultures lack this capability. These data indicate that
exosomes carry signaling information required to regulate neural
circuit development.
exosomes | Rett syndrome | neuronal development | synaptogenesis |
extracellular vesicle
Exosomes are small vesicles secreted by all cells in the brain,including neurons, and have been hypothesized to play a
critical role in cell–cell communication (1, 2). Exosomes can
signal over short range within brain tissue (3), and can signal
widely throughout the brain through the cerebrospinal fluid (4,
5). Strong evidence indicates that exosomes impart biological
activity to neurons (3, 6). For instance, in the Drosophila larval
neuromuscular junction, exosome-mediated protein transport is
required for coordinated development of pre- and postsynaptic
components of the neuromuscular junction (7, 8). Exosomes
secreted by oligodendrocytes affect firing rate, signaling
pathways, and gene expression in cultured primary neurons (9,
10). Although there is evidence of biological roles of exosomes
secreted by neurons and other cell types in the brain, their
function in the development of human neural circuits is
largely unexplored.
To investigate the role of exosomes in neural circuit devel-
opment, we developed a reductionist experimental paradigm in
which we added purified exosomes isolated from human induced
pluripotent stem cell (hiPSC)-derived neurons onto human pri-
mary neural cultures to assay their capacity to influence neuronal
and circuit development. We found that treatment with exosomes
increased neurogenesis by promoting cell proliferation and
neuronal differentiation, suggesting that exosomes carry signal-
ing components that influence cell fate in developing neural
circuits. We injected purified rodent exosomes into the lateral
ventricle of P4 mice to test their role in hippocampal neuro-
genesis in an in vivo model. Consistent with in vitro observations,
exosome treatment increases in proliferation in the granule cell
layer (GCL) of dentate gyrus. Based on these observations that
exosomes affect neural circuit development in vitro and in vivo,
we hypothesized that conditions that disrupt neural circuit de-
velopment may arise from defective exosome signaling. The loss
of function of the X-linked Methyl-CpG-binding protein 2 (MECP2)
gene results in aberrant neural circuit development, leading to
Rett syndrome (11–14). As disruption of a single protein, MECP2,
leads to widespread pleiotropic deficits in neural circuit develop-
ment, we further hypothesized that altered exosome-mediated
intercellular communication may contribute to the impaired
neural circuit development seen with MECP2 loss of function
(MECP2 LOF). We had previously shown that neurons derived
from MECP2 LOF hiPSC-derived neurons have fewer synapses,
reduced spine density, smaller soma size, altered calcium signal-
ing, and electrophysiological defects compared with control neurons
(15), whereas CRISPR/Cas9 isogenic rescue of the MECP2 mu-
tation (referred to as isogenic control) results in normal neural
cultures (16, 17). Here, we compared exosomes released from
MECP2 LOF donor neural cultures with exosomes from isogenic
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control donor neural cultures by using quantitative proteomic
analysis. Isogenic control exosomes differed significantly from
MECP2 LOF exosomes in their protein signaling content.
Bioinformatic analyses revealed signaling complexes in control
exosomes capable of eliciting neurodevelopmental outcomes,
such as neural cell proliferation, neurogenesis, and synaptic
development, that were lacking in MECP2 LOF exosomes.
Treating recipient MECP2 LOF cultures with exosomes from
isogenic control donor cultures increased cell proliferation,
neurogenesis, synaptogenesis, and synchronized firing, whereas
treating control recipient neural cultures with exosomes from
MECP2 LOF donor cultures did not have adverse effects on
neural phenotypes. These data show that exosomes play a sig-
nificant role in neuronal circuit development and can be used
to reverse deficits in neurological disease models.
Results
Exosomes Increase Cell Number in Developing Neural Cultures. To
test the hypothesis that exosomes play a physiological role in
neuronal development, we established neural cultures derived
from hiPSCs as a source for exosomes because of the demon-
strated value of iPSCs in modeling human diseases (15–17) and
the capacity to harvest large volumes of exosomes. We cultured
hiPSC-derived neural cultures in serum-free growth and differ-
entiation media to avoid potential contamination from exosomes
from serum. The hiPSC-derived neural cultures used in this study
have been well characterized and contain approximately 90%
neurons and 10% glia (15). Exosomes were purified by using a
differential centrifugation protocol (18), slightly modified for our
cultures (Fig. 1A). Western blot analysis showed that the purified
exosomes contain the typical exosome markers, Alix and Flotillin
(Fig. 1B). Electron microscopic analysis demonstrated that the
purified exosomes had typical disk-shaped morphology (Fig. 1C
and SI Appendix, Fig. S1) and ranged in size from 30 to 200 nm;
∼60% of exosomes were between 40 and 80 nm and >80%
were <120 nm (Fig. 1D).
To investigate the effect of exosomes on neural development
we first characterized proliferation and differentiation in the
human primary neural cultures. Proliferation, assessed by EdU
incorporation, was maintained over the first 9 d in vitro (DIV),
after which proliferation declined (SI Appendix, Fig. S2). We
isolated exosomes from 2-d conditioned media harvested from
donor neural cultures derived from differentiated hiPSCs as in
Fig. 1A. Purified exosomes were washed and resuspended in
fresh growth media and applied to recipient neuronal cultures on
5, 7, and 11 DIV (Fig. 1E). Purified exosomes, labeled with
fluorescent membrane label, ATTO 488 mCLING (19), are
taken up by neurons and distributed to the cell body and different
cellular compartments, including synapses (SI Appendix, Fig. S3).
Recipient primary human neural cultures, labeled with DAPI and
MAP2 (Fig. 1 F andG), showed a statistically significant increase in
Fig. 1. Exosomes increase proliferation in vitro and in vivo. (A) Protocol to purify exosomes by sequential ultracentrifugation. (B) Western blot analysis
showing exosomal markers Alix and Flotillin in exosomes purified from human iPSC-derived neural cultures. (C) Electron micrograph of purified exosomes.
Arrows point to exosomes with typical disk-shaped morphology. (D) Size distribution of exosomes purified from human iPSC-derived neural cultures. Vesicle
diameter was calculated from electron micrographs. (E) Protocol for treatment of human primary neural cultures with purified control exosomes (Co Exo) or
an equal volume of media (No Exo) added on DIV 5, 7, 9, and 11. Cultures were fixed on DIV 13, labeled, and analyzed. (F and G) Images of human neural
cultures treated with media (No Exo, F) or control exosomes (Co Exo, G) labeled with MAP2 antibodies (green) or DAPI (red). (H) Graph of the total cell
number in cultures treated with control exosomes compared with media alone (No Exo). Exosome treatment increased total cell number 1.65× ± 0.08 (P =
0.001, n = 4 wells per group, 2-way ANOVA). (I and J) Protocols for preparation of exosomes purified from E18 rat primary neural cultures (I) and treatment of
P4 mice (J). Exosomes were purified from serum-free media collected from DIV9 rat neural cultures, and the 100,000 × g exosome pellet was equally divided
into 2 tubes. One tube was treated with 100 μg/mL Proteinase K at 37 °C for 30 min to cleave surface proteins, and the other tube was left untreated. P4 mice
received exosome injections into the lateral ventricles (LV), followed by intraperitoneal (ip) injections of 25 mg/kg of EdU. The mouse brains were fixed and
processed to detect EdU+ cells. (K–N) Images of hippocampal dentate gyrus of P4 mice injected with protein-depleted exosomes (K and L) and untreated
exosomes (M and N) showing EdU+ cells (red), Nestin (green) immunolabeling, and TO-PRO-3 nuclear stain (blue). Low-magnification images were used to
match identical brain regions (SI Appendix, Fig. S3). EdU+ cells were counted in the boxed regions in dentate gyrus region (K–M), shown at 3.3× zoom in L–N.
Proliferation in the granule cell layer (GCL) of the dentate gyrus was quantified by counting EdU+ cells normalized to the area counted. (O) Exosome
treatment increased Edu+ cells per unit area 1.34× ± 0.12 (n = 3 mice each) compared with proteinase K-treated exosomes. (Scale bars: C, 0.1 μm; F, G, K, and
M, 20 μm.)
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cell number in exosome-treated cultures compared with control
(1.65× ± 0.08; P = 0.001, Fig. 1H).
Exosomes Increase Proliferation In Vivo in Mouse Dentate Gyrus. To
test whether exosomes display bioactivity in vivo and can influ-
ence cell proliferation in developing neural circuits analogous to
neural cultures, we measured neural proliferation in the GCL of
dentate gyrus in postnatal P4 mice, where granule cell pro-
liferation continues during this early postnatal period (20, 21).
We harvested exosomes from DIV9 rodent primary neural cul-
tures and injected them into the lateral ventricles of P4 mice
(Fig. 1 I and J). As a control, we injected exosomes treated with
Proteinase K, which are depleted of protein (SI Appendix, Fig.
S5). Exosome injections in each cerebral hemisphere were fol-
lowed by i.p. administration of 5-ethynyl-2′-deoxyuridine (EdU;
25 mg/kg of body weight). The brains of treated mice were fixed
after 24 h, and sagittal vibratome sections were labeled with
DAPI, Nestin, and EdU. Anatomically matching sections were
identified in low-magnification images (SI Appendix, Fig. S4),
and EdU+ cells were counted in the GCL (Fig. 1 K–N). Mice
injected with DIV19 exosomes had significantly greater EdU+
cell density in the GCL compared with pups with control
protein-depleted exosomes (1.34× ± 0.12; P < 0.05; Fig. 1O).
These data indicate that exosomes display bioactivity in vivo, in-
creasing neural cell proliferation, analogous to their effect in neural
cultures.
Proteomic Analysis Indicates That Exosomes Contain Signaling Proteins
That Are Lacking in the Absence of MECP2. To explore the idea that
proteins may be involved in exosome intercellular signaling capacity
in neural circuit development, we analyzed the proteomes of
exosomes in a model of the neurodevelopmental disorder Rett
syndrome, in which functional disruption of a single protein, MECP2,
has devastating effects on brain development. We conducted an
unbiased quantitative mass spectrometry (MS) proteomic study
of exosomes using TMT isobaric tags. We compared purified
exosomes from donor hiPSC-derived neural cultures from a male
individual, in which MECP2 protein was completely absent
(MECP2LOF), with control isogenic hiPSC-derived neural cul-
tures that were corrected for the MECP2 mutation using
CRISPR/Cas9 technology (isoCONTROL exosomes) (16). We
detected a total of 2,572 proteins from MECP2LOF and control
exosomes in 2 independent MS experiments (SI Appendix, Fig. S6A
and Datasets S1–S3), of which 739 were annotated for function in
neurons. Analysis of “cellular pathways” and “downstream effects
on biological functions in the nervous system” using the manually
curated Ingenuity database (22) indicated that exosomes released
by hiPSC-derived neural cultures are enriched in proteins that
impact neuronal development and function (SI Appendix, Fig. S6 B
and E and Datasets S6 and S8). Specifically, they contain signaling
components for protein translation, axonal guidance, integrin sig-
naling, ephrin signaling, and cytoskeletal regulation (Rho family,
Actin cytoskeleton), among the most significant categories (SI
Appendix, Fig. S6B and Dataset S6), and have the capacity to in-
fluence downstream functions such as neuritogenesis, development,
morphogenesis and proliferation of neurons, and synaptic devel-
opment and function (SI Appendix, Fig. S6C and Dataset S8). We
do not detect synaptic vesicular neurotransmitter transporters, early
endosomal markers, and nuclear markers in the exosome proteome
(SI Appendix, Fig. S7).
Of the 2,572 proteins present in MECP2LOF and isoCONTROL
exosomes, 237 had an average fold difference of 1.5 or more
between MECP2LOF and isoCONTROL samples (Fig. 2 and
Dataset S4). We analyzed this dataset of 237 proteins by using
the Ingenuity database and the PANTHER Overrepresentation
Test (23) and GO enrichment using FunCoup (24). The PANTHER
Overrepresentation Test using the GO “biological processes”
complete annotation dataset indicated that “nervous system
Fig. 2. Exosomes contain signaling proteins that are altered with MECP2LOF.
(A) Quantitative mass spectrometry comparing exosomes from MECP2LOF or
isogenic CRISPR control hiPSC-derived neural cultures identified 2,572 pro-
teins. The PANTHER overrepresentation test was performed on the dataset
of 237 proteins with >1.5× change between MECP2LOF or control
exosomes using the GO “biological processes” complete annotation dataset.
The 237 candidates were classified into annotated GO biological process
categories and compared with the normal human database to determine
whether they are overrepresented or underrepresented for a given GO bi-
ological process. Fold enrichment (x-axis) is the ratio of proteins classified in
each GO category from the experimental dataset relative to the number of
proteins predicted to be in the GO category from the reference normal
human dataset. Positive values indicate overrepresentation of the GO cat-
egory in the experimental dataset. The y-axis shows the top 10 GO biological
processes by P values plotted as a heat map, where color intensity depicts
−log(P value) from 15.98 (bright red) to 10.38 (light red). “Neurogenesis” and
“nervous system development” are among the most significantly enriched
GO categories. (B) Top 10 canonical pathways from Ingenuity analysis using
the dataset of 237 proteins. Blue bars, associated with the left y axis, show
significance values plotted as −log(P value), and square orange markers,
associated with the right y-axis, show the overlap ratios of the number of
proteins from our dataset relative to the total number of proteins annotated
to each canonical pathway. (C) Bubble chart showing Ingenuity analysis of
the relative strength of downstream effects for biological functions and
diseases in the nervous system using the dataset of 237 proteins
showing >1.5× difference. The top 10 predicted biological functions are
plotted vs. significance values plotted as −log(P values), where the bubble
size represents the number of proteins from the dataset annotated for given
function. The data values for bubble sizes are shown on the bubbles. (D)
Functional protein association networks of 2 predicted biological functions
from C, neuronal development and neuronal proliferation, are plotted by
using the STRING database. The exosome proteins involved in 2 functions
form robust networks and show significant overlap. The line thickness rep-
resents the confidence of association from highest (0.9) to medium (0.4).
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development” (+2.88×) and “neurogenesis” (+3.26×) were highly
overrepresented compared with the normal human database (Fig.
2A and Dataset S5). Ingenuity analysis of the representation of
components with a role in different cellular functions indicated that
“axon guidance,” “ephrin signaling,” and “actin dynamics” are
among the most significant (Fig. 2B and Dataset S7). The Ingenuity
Pathway Analysis (IPA)-curated “downstream effects on biological
functions in the nervous system” predicted roles in “neuronal de-
velopment,” “neuritogenesis,” “axonal guidance,” “proliferation of
neurons,” and “synaptic development” among the most significant
categories (Fig. 2C and Dataset S9). We further analyzed the
dataset of 30 proteins predicted to be involved in neuronal pro-
liferation and dataset of 44 proteins predicted to be involved in
neuronal development. There was significant overlap between the
2 datasets consistent with proteins annotated to perform function in
neuronal proliferation as well as development (Fig. 2D). Both
datasets showed robust functional protein association networks
using STRING database (Fig. 2D). These quantitative proteomic
and bioinformatic analyses indicate that exosomes contain proteins
that interact in complex functional signaling networks that are
significantly altered by MECP2 mutation. To test whether alter-
ations of specific proteins in exosomes released from MECP2LOF
donor cultures reflects similar alterations in cellular levels of the
proteins, we compared protein expression in MECP2LOF donor
cells and exosomes with isoControls using Western blots (SI Ap-
pendix, Fig. S2B). Differences in cargo between MECP2LOF and
isoControl exosomes were largely independent of their cellular
expression. Whereas HRAS and Alix showed similar levels in
isoCONTROL and MECP2LOF cell lysates, Alix was reduced
and HRAS was unchanged in MECP2LOF compared with
isoCONTROL in exosomes. Flotillin, Cadherin 2, Calmodulin 1,
GAP43, and L1CAM showed higher protein levels in cells with
MECPLOF compared with isoCONTROL. In contrast, Flotillin
and GAP43 were reduced in MECP2LOF exosomes, whereas
Cadherin 2 and L1CAM were unchanged. These results indicate
that MECP2 loss-of-function leads to specific protein alterations
in exosomes and that exosome protein cargo is not merely a
replica of cellular alterations. Mechanisms underlying the differ-
ential packaging of exosome cargo have yet to be elucidated.
Control Exosomes Increase Proliferation and Neuronal Differentiation
Whereas MECP2LOF Exosomes Have No Effect. The proteomic
analysis just described predicts that MECP2LOF and control
exosomes may have different effects on cell proliferation and
neuronal differentiation. To test these hypotheses, we treated
recipient human primary neural cultures with exosomes from
MECP2LOF or control donor cultures on DIV 5 and 7 (Fig. 3A).
On DIV 7, cultures received a 2-h pulse of 10 μM EdU before
addition of exosomes. The cultures were fixed on DIV 9, and
EdU-labeled NPC progeny were analyzed to assess cell pro-
liferation. The isoCONTROL exosome treatment increased
EdU labeled progeny by a factor of 1.35× ± 0.09 (P = 0.006)
compared with no exosome treatment, whereas treatment with
MECP2LOF exosomes was comparable to addition of media
alone (Fig. 3 B–E). These data indicate that isogenic control
exosomes promote NPC proliferation and survival of EdU-
labeled progeny, whereas these proliferation and survival sig-
nals are lacking in MECP2LOF exosomes, consistent with our
proteomic data analysis.
To investigate whether cells generated in response to exosome
treatment differentiate into neurons, we birth-dated cells with EdU,
then immunolabeled the cultures with doublecortin (DC), a marker
of immature neurons, and GFAP, to identify astrocytes. The
isoCONTROL exosome treatment increased EdU+DC+ double-
labeled neurons 2.8× ± 0.27 (P = 0.005) compared with control
conditions (media alone, no exosomes), whereas MECP2LOF exo-
some treatment did not affect numbers of EdU+DC+ double-
labeled neurons (Fig. 3 F–I). The isoCONTROL and MECP2LOF
exosome treatments both increased EdU+GFAP+ double-labeled
astroglia compared with addition of media alone (Fig. 3 J–M),
indicating that increased astroglia generation was proportional to
the increase in progeny. These results show that isoCONTROL
exosomes enhance neuronal fate and expand the neuronal pool.
Whereas MECP2LOF and control exosomes had an equiva-
lent capacity to enhance astroglial formation, MECP2LOF exosomes
lacked signals that influence neuronal fate. These results are con-
sistent with our proteomic data analysis predicting neurogenic
effects of exosome cargo (Fig. 2D). The selective effect of
MECP2LOF exosomes on increased astrocyte fate supports
previous studies demonstrating a beneficial role for noncell au-
tonomous signaling from astrocytes to neurons in a mouse model
of Rett syndrome (25).
Fig. 3. Isogenic control exosomes increase proliferation and neuronal fate
in developing neural cultures, whereas MECP2LOF exosomes have no effect.
(A) Protocol for treatment of human primary neural cultures with exosomes
to assay proliferation, survival, and cell fate. Human primary neural cultures
were treated with media alone or exosomes on DIV 5 and 7. On DIV 7,
cultures were exposed to 10 μM EdU for 2 h just before the second exosome
or media treatment. Cultures were fixed and immunolabeled for analysis on
DIV 9. (B–E) Isogenic control exosomes increase cell proliferation. (B–D)
Confocal images show EdU-labeled human neural cultures treated with
media (B, No exo), isogenic control exosomes (C, IsoCo exosomes), and
MECP2LOF exosomes (D). (E) Treatment with isogenic control exosomes
(gray bars) increased EdU-labeled progeny by 1.35× ± 0.09 (P = 0.006)
compared with no exosomes (white bar), whereas MECP2LOF exosome
treatment (black bars) had no effect (E). Edu+ cell numbers normalized to
no-media condition. (F–I) Isogenic control exosomes increase neuronal dif-
ferentiation. Confocal images of EdU-labeled (red) and doublecortin-labeled
(green) cultures treated with media (F), isogenic control exosomes (G), and
MECP2LOF exosomes (H). Control exosomes (gray bars) increased neuronal
progeny 2.8× ± 0.27 (P = 0.005), whereas MECP2LOF exosomes (black bars)
had no effect (I). (J–M) Isogenic control exosomes and MECP2LOF exosomes
increase astrocyte differentiation. Confocal images of EdU-labeled (red) and
GFAP-labeled (green) cultures treated with media (J), isogenic control exo-
somes (K), and MECP2LOF exosomes (L). Control as well as MECP2LOF exo-
some treatments increase Edu+GFAP+ astroglial progeny by 1.4× ± 0.09 (P =
0.006) and 1.4× ± 0.13 (P = 0.009), respectively (M). n = 4 wells per group.
Statistics computed with 2-way ANOVA with Bonferroni correction. (Scale bar,
20 μm.)
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isoCONTROL Exosomes Restore Number of Neurons in MECP2-Knockdown
Neural Cultures.To test the effect of control exosome treatment on
MECP2LOF neural cultures, we knocked down MECP2 in hu-
man neural cultures by usingMECP2 shRNA lentivirus, as in our
previous study (15). MECP2 shRNA or scrambled control len-
tivirus (shMECP2 or shScrambled) was added to human primary
neural cultures on DIV 3, followed by treatment with iso-
CONTROL exosomes on DIV 5, 7, 9, and 11 (Fig. 4A). We
tested the effect of 3 doses of isoCONTROL exosomes on
MECP2-knockdown cultures by serially diluting the purified
exosomes (1× dose) to 0.5× and 0.25× relative concentrations to
investigate the relationship of dose with bioactivity. The cultures
were fixed on DIV 13 and immunolabeled with the neuronal
marker Synapsin and DAPI (Fig. 4 B–E and SI Appendix, Fig.
S7). We used insulin like growth factor-1 (IGF1) as a positive
control (Fig. 4E), as it has been shown to partially restore some
of the MECP2 loss-of-function phenotypes by increasing ex-
pression of synaptic proteins, enhancing excitatory synaptic
transmission, and restoring dendritic spine densities (15). Without
exosome treatment, MECP2KD decreased total cell numbers and
neurons compared with shScrambled control cultures (Fig. 4 F–H
and SI Appendix, Fig. S7A). Treatment with isoCONTROL exosomes
rescued the decreased total cell number (Fig. 4 B, C, and F and SI
Appendix, Fig. S7 A–D) and the decrease in neurons in the
MECP2KD cultures (Fig. 4 B, C, and G and SI Appendix, Fig. S7
A–D) and increased total cell number and neurons in shScrambled
control cultures (Fig. 4 G and I). Whereas the 1× dose of control
exosomes was ineffective, the 0.5× and 0.25× doses produced
complete rescue, in contrast with partial rescue with IGF treatment.
To test whether MECP2LOF exosomes could contain negative
signals that contribute to MECP2LOF phenotypes (15), we
treated neural cultures with the control scScrambled virus and
then added MECP2LOF exosomes harvested from the hiPSC-
derived neural donor cultures on DIV 5, 7, 9, and 11 (Fig. 4A).
We tested 3 doses of MECP2LOF exosomes by serially diluting
the 1× stock to 0.5× and 0.25×. The cultures were fixed on DIV
13 and immunolabeled with Synapsin and DAPI to determine
numbers of neurons and total cells respectively. Whereas treat-
ment with isoCONTROL exosomes increased total cell number
and the number of neurons compared with addition of media
alone (Fig. 4 D, E, G, and I and SI Appendix, Fig. S7 E–H),
MECP2LOF exosomes did not show an adverse effect on total
cell number or numbers of neurons (Fig. 4 G and I). On the
contrary, the 0.5× dose of MECP2LOF exosomes increased the
total cell number compared with control cultures without exo-
some addition (Fig. 4G). These results suggest that MECP2LOF
exosomes are capable of signaling. The data further suggest that
MECP2LOF exosomes do not have a dominant acute deleteri-
ous effect on cell proliferation or neuronal differentiation. To-
gether with our proteomic analysis, these results suggest that
isoControl exosomes contain signaling codes that are likely to
have different outcomes depending on dose and the state of
recipient cells. They further suggest that MECP2LOF exosomes
lack signals that increase neuronal differentiation.
Control Exosome Treatment Increases Synapse Density and Neuronal
Firing in MECP2LOF hiPSC-Derived Neurospheres. MECP2 knock-
down in human neuronal cultures decreases synapses and
activity-driven calcium transients compared with control neurons
(15). We tested whether isogenic control exosomes have the
capacity to rescue these synaptic and circuit deficits. To assay the
effect of exosome treatment on synaptogenesis, we differentiated
MECP2LOF hiPSC-derived NPCs into mature 6-wk-old neural
cultures and treated the cultures 4 times with 1× or 0.25× doses
of control exosomes over 8 d, as described in Fig. 5A. After
exosome treatments, the cultures were fixed and labeled with
antibodies against MAP2 to label neurons and Synapsin1 to label
presynaptic puncta. Images were analyzed for quantitative changes
in synaptic puncta number and intensity. Neural cultures treated
with the low dose of control exosomes had significantly higher
puncta density compared with cultures without exosome treatment
(Fig. 5 B–D). Furthermore, treatments with control exosomes shift
the distribution of puncta intensities toward lower intensities (Fig.
5E), suggesting that the increase in synaptic density seen in Fig. 5D
may be caused by an increase in lower-intensity puncta. Together,
these data suggest that control exosomes increase synaptogenesis in
MECP2LOF hiPSC-derived neural cultures.
Neurospheres generated from hiPSC-derived neural cells are a
convenient 3-dimensional experimental system for measuring
neuronal activity and connectivity in a network using multielec-
trode arrays (MEAs). Neurospheres mature into a network that
displays synchronized neuronal firing (26). To test whether
exosome treatments affect circuit development, we analyzed
neuronal firing in neurospheres treated with control exosomes
compared with MECP2LOF exosomes, which do not appear to
have deleterious effects on neuronal differentiation (Fig. 4). We
generated neurospheres from hiPSC MECP2LOF-derived NPCs
and plated them onto MEAs (Fig. 5F). Neurospheres were
treated with exosomes 4 times over 8 d (Fig. 5A), and activity
across the MEA was evaluated. Raster plots of spike recordings
from individual electrodes show that neuronal firing in MECP2LOF
neurospheres treated with MECP2LOF exosomes is sparse and
activity across electrodes is not synchronized (Fig. 5H). By con-
trast, treatment with control exosomes increased neuronal ac-
tivity in MECP2LOF neurospheres compared with treatment
with MECP2LOF exosomes. In particular, neurospheres treated
with control exosomes had more activity per channel and more
active channels than neurospheres treated with MECP2LOF
exosomes (Fig. 5 H and I). Furthermore, the aligned raster plots
showed more synchronized activity across multiple channels in
neurospheres treated with control exosomes compared with
neurospheres treated with MECP2LOF exosomes (Fig. 5 H and
I), indicating that control exosome treatment increases neuronal
and network activity in MECP2LOF neurospheres. Together,
these results indicate that control exosome treatments are ca-
pable of increasing presynaptic puncta density and increasing
activity in neural circuits.
Discussion
The potential function of exosomes in neural circuit develop-
ment is unclear. Here we show that exosomes play a profound
role in neural circuit development leading to enhanced neural
progenitor proliferation, neuronal differentiation, and circuit con-
nectivity. Furthermore, we show that exosomes from MECP2LOF
hiPSC-derived neural cultures fail to promote neural circuit
development, whereas exosomes from isogenic control hiPSC-
derived neural cultures ameliorate developmental deficits, in-
cluding neurogenesis, synaptogenesis, and circuit connectivity, in
human neural cultures or neurospheres with MECP2LOF.
Quantitative proteomic analysis showed that exosomes from
human neural cultures are enriched in proteins known to play
diverse roles in neuronal circuit development. Exosomes from
MECP2LOF and control neural cultures differed significantly in
signaling proteins involved in neuronal circuit development.
Together our data demonstrate that exosomes facilitate the de-
velopment of human neural circuits, that treatments with control
exosomes rescue neurodevelopmental defects in a model of Rett
syndrome, and that mutation of a single gene, MECP2, results in
large-scale changes in exosome protein cargo and exosome
signaling bioactivity.
Exosomes have been hypothesized to play important roles in
the nervous system and have been shown to be involved in
neurodegenerative disorders (4, 27–29), axonal pathfinding (30),
and synaptic pruning (31); however, the potential role of exosomes
in normal neural development or neurodevelopmental disorders is
unclear. Here, we provide quantitative analysis of differences in
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proteomic content of exosomes from MECP2LOF iPSC-derived
neural cultures compared with CRISPR/Cas9-corrected isogenic
control exosomes. The use of isogenic control neural cultures
generated by correcting theMECP2mutation minimizes effects of
differences in genetic background to parse out differences spe-
cifically resulting from MECP2 mutation. Our proteomic analysis
identified ∼240 differentially expressed neural proteins between
MECP2LOF and control exosomes, which are predicted to affect
proliferation, neuronal development, and synaptic maturation of
neurons, leading to abnormal connectivity of neural circuits. Our
data indicate that exosomes play diverse roles in neuronal circuit
development. Given the spatial and temporal complexity of circuit
development, we used an experimental design in which we ex-
amined the effects of exosome treatments at different de-
velopmental time points of circuit development. This allowed us to
demonstrate effects of exosomes on cell proliferation, assayed at
relatively early time points; neuronal differentiation and apopto-
sis, assayed at intermediate time points; and synaptogenesis and
circuit connectivity, assayed at later time points. It is interesting to
note that, for any given neurodevelopmental function, exosome
cargo includes multiple components within candidate signaling
pathways, and also includes both positive and negative regulators.
This complexity of exosome cargo suggests that it is unlikely that
any individual cargo would account for particular neurodevelo-
pmental outcomes we have studied. In addition, many classes of
signaling molecules, like Ephrins and Trk receptors, play distinct
roles in neuronal development and function that change over time
and place, consistent with our observations that different doses of
exosomes affect different outcome measures, such as prolifera-
tion, differentiation, and synaptogenesis. The diverse outcomes of
exosome treatments we observe are consistent with proteomic
cargo identified in control exosomes. Taken together, these data
suggest that the effect of exosome signaling is likely to be a
combinatorial sum of overlapping and sometimes opposing sig-
naling networks, consistent with our observation that different
doses of exosomes generate different responses in neurodevelopmental
outcome measures.
Our data indicate that treatment with exosomes released from
control neural cultures rescue several phenotypes of deficient
neural circuit development seen with MECP2KD in vitro (15),
including deficits in neurogenesis, synaptogenesis, and neural
circuit connectivity. These data are consistent with the proteomic
data indicating that exosome cargo are predicted to affect mul-
tiple processes that occur over the course of neural development.
An important feature of exosomes is that they can signal over a
variety of length scales and act non–cell-autonomously. This may
be particularly relevant to studies that have shown that restora-
tion of MECP2 function in glia can rescue neuronal and be-
havioral deficits in mouse models, consistent with long-range
non–cell-autonomous mechanisms underlying rescue (25).
Exosomes have been hypothesized to play a pathological role
in several neurological disorders, particularly proteinopathies, by
spreading pathological molecules to healthy tissue. Alternatively,
exosomes have been postulated to play a protective role by
dumping pathological molecules out of cells (32, 33). In the
context of healthy human neural cultures, we find that exosome
treatment promotes neural development. In the context of the
neurodevelopmental deficits resulting from MECP2 loss of
function, our data indicate that MECP2LOF exosomes do not
play a pathogenic role in circuit development. Furthermore,
Fig. 4. Control exosomes rescue the reduced number of neurons resulting
from MECP2 knockdown, but MECP2LOF exosomes have no adverse affect.
(A) Protocol for treatment of human primary neural cultures with exosomes
to assay changes in neurons. Human primary neural cultures were infected
with lentivirus expressing shRNA to knock down MECP2 (green bars in F–H)
or control scrambled shRNA (blue bars in F–I). Cultures were treated with
media alone (No exosomes, white bars in F–I), 1×, 0.5×, or 0.25× dose of
control exosomes (gray bars in F–I) or MECP2LOF exosomes (black bars in F–I),
or 10 ng/mL IGF (striped bars in F–H) on DIV 5, 7, 9, and 11. On DIV 13,
cultures were fixed and immunolabeled with Synapsin1 and counterstained
with DAPI to quantify the number of neurons and total cells, respectively.
(B–E) DAPI labeling (grayscale; Top) and results from independent experi-
ments (Bottom) with separate DAPI (red) and Synapsin1 (green) double-
labeled wide-field fluorescent images from cultures with MECP2 knock-
down (MECP2KD) treated with media alone (no Exo; B) and 0.25× control
exosomes (C). Images from cultures with control shRNA and no exosomes (D)
or isogenic control exosomes (E). (F and G) Plots of cell counts normalized to
control cultures with no exosomes (no Exo shCO). MECP2KD (shMECP2, no
exosomes) reduces the number of cells to 0.24× ± 0.07 (P = 0.0001) of control
conditions (scrambled shRNA control, No exosomes). Treatment with 0.5×
and 0.25× doses of control exosomes rescued the decreased cell number seen
with MECP2KD without exosomes to 0.88× ± 0.19 (P = 0.0001 vs. MECP2KD,
no exosomes) and 1.25× ± 0.22 (P = 0.0001 vs. MECP2KD, no exosomes) of
control, respectively. IGF treatment showed partial rescue to 0.57× ± 0.03
(P = 0.007 vs. MECP2KD, no exosomes) of control. (G) MECP2KD (No exo-
some) decreases the number of neurons to 0.42× ± 0.09 control (CO-No
exosome; P = 0.0001). Treatment with 0.5× control exosomes and 0.25×
control exosomes rescued the number of neurons to 1.05× ± 0.09 and
1.22× ± 0.15 of control, respectively (P = 0.0001 each vs. MECP2KD, no
exosomes). IGF treatment showed partial rescue to 0.8× ± 0.03 of control
(P = 0.003 vs. MECP2KD, no exosomes). (H and I) In human primary neurons
infected with lentivirus expressing control scrambled shRNA, treatment with
isogenic control exosomes increased the number of cells 2.05× ± 0.69 (P =
4.4 × 10−4) compared with controls (no exosome) (H). The treatment with
0.5×MECP2LOF exosomes increased the number of cells by 1.48× ± 0.38 (P =
0.0001), whereas treatments with 1× MECP2LOF and 0.25× exosome doses
did not show statistical differences from control. (I) Control exosome treat-
ment increased the number of neurons 1.36× ± 0.08 (P = 0.004) compared
with control (no exosomes), but none of the MECP2LOF exosome treatments
altered neuron numbers compared with control (n = 3 for each group).
Statistics computed with 2-way ANOVA with Bonferroni correction. (Scale
bar, 20 μm.) ns, not significant.
Sharma et al. PNAS | August 6, 2019 | vol. 116 | no. 32 | 16091
N
EU
RO
SC
IE
N
CE
MECP2LOF exosomes neither rescue nor exacerbate neuronal
circuit defects resulting from MECP2LOF.
In conclusion, our data demonstrate that neural exosomes
have intercellular signaling bioactivity that has functional impact
in a neurodevelopmental disease model. Furthermore, we show
that exosomes are able to reverse some of the pathological
phenotypes observed in MECP2 mutant neurons, indicating that
exosomes could have therapeutic applications in brain disorders.
Experimental Methods
All procedures and protocols have been approved by the Institutional Animal
Care and Use Committees at The Scripps Research Institute and University of
California San Diego.
Human iPSC-Derived Neural Cultures. To generate neural progenitor cells
(NPCs), cells were differentiated and maintained as previously described (15,
34). A male patient cell line with MECP2 Q83X (noted as MECP2 LOF) mu-
tation, its male parental control, and an isogenic rescue, corrected using
CRISPR/Cas9 genome editing, were used in this study (16). Two different
clones of control (isogenic rescue or father of Q83X patient, WT83) iPSCs and
MECP2LOF iPSCs were used in our studies to mitigate line-to-line variation.
iPSCs lines maintained in mTESR media were switched to N2 (DMEM/F12
media supplemented with 1× N2 NeuroPlex Serum-Free Supplement [Gemini]
with the dual SMAD inhibitors, 1 μM of dorsomorphin [Tocris], and 10 μM of
SB431542 [Stemgent]) daily for 48 h. After 2 d, colonies were scraped off and
cultured under agitation (95 rpm) as embryoid bodies (EB) for 7 d using
N2 media with dorsomorphin and SB431542. Media was changed every other
day. EBs were then plated onMatrigel-coated dishes and maintained in DMEM/
F12 supplemented with 0.5× of N2 supplement, 0.5× Gem21 NeuroPlex Serum-
Free Supplement (Gemini), 20 ng/mL basic fibroblast growth factor (bFGF;
LifeTechnologies), and 1% penicillin/streptomycin (P/S). After 7 d in culture,
rosettes from the plated EBs were manually selected, gently dissociated with
StemPro Accutase (Life Technologies), and plated onto 10 μg/mL poly-L-
ornithine (Sigma)/5 μg/mL Laminin (Life Technologies)-coated plates. NPCs
were maintained in DMEM/F12 with 0.5× N2, 0.5× Gem21, 20 ng/mL bFGF,
and P/S. NPCs were expanded as soon as they had reached confluence by
using StemPro Accutase for 5 min at 37 °C, centrifuged, and replated with
NGF with a 1:3 ratio in poly-L-ornithine/Laminin-coated plates. To induce
cortical neuron differentiation, FGF was retrieved as previously described
(15). The cortical neurons were allowed to differentiate for 4 wk before
exosome collection. The media was collected every 2 d for exosome iso-
lation. All media formulations used were serum-free.
All cell lines used have been authenticated. All cell lines have tested
negative for mycoplasma. Cytogenetic analysis was performed in all clones to
evaluate correct cell karyotype (Children’s Hospital Los Angeles). In addition,
all cell lines have been genotyped to ensure the presence of the mutation.
The absence of the MECP2 protein in the patient cell line has been verified
by immunohistochemistry.
Human Primary Neural Cultures. Human primary neurons were purchased
from ScienCell (cat. no. 1520), without identification of sex. Cells were thawed
and plated according to the manufacturer’s instructions. After thawing, cells
were counted, and 20,000 cells per 96-well plate were plated in serum-free
ScienCell Neuronal Medium (cat. no. 1521) onto 10 μg/mL poly-L-ornithine
(Sigma)/5 μg/mL Laminin (Life Technologies)-coated plates. Cells were in-
fected with lentivirus expressing shRNA targeted to MECP2 (shMECP2) or
scrambled control shRNA (shControl) as described previously (15). As a pos-
itive control in the rescue experiments, 10 ng/mL of IGF1 was added to the
cultures (cat. no. 100–11R3; PeproTech).
Exosome Purification from hiPSC-Derived Neural Cultures. Exosomes were
enriched from serum-free media from hiPSC-derived neural cultures as de-
scribed in Fig. 1A (18). Fresh media was replaced in cultures 2 d before
collecting exosomes. After 2 d, culture media was harvested for exosome
isolation and replaced with fresh growth media. For multiple treatments,
exosomes were harvested from the media collected from the same cultures
every 2 d. The harvested media was centrifuged at 300 × g for 15 min at 4 °C,
and the supernatant was collected and centrifuged at 2,000 × g for 15 min at
4 °C in a Beckman tabletop centrifuge. The second supernatant was further
centrifuged using a Beckman ultracentrifuge at 10,000 × g for 45 min at 4 °C.
The supernatant was collected and centrifuged at 100,000 × g for 1 h at 4 °C
to pellet exosomes. The exosome pellet was washed twice with D-PBS solu-
tion containing Ca2+ and Mg2+ (GIBCO) at 100,000 × g for 1 h at 4 °C, followed
by resuspension in normal serum-free growth media described earlier.
Fig. 5. Control exosome treatment increases synapse density and neuronal
firing in MECP2LOF hiPSC-derived neurospheres. (A) Protocol for treatment
of MECP2LOF hiPSC-derived neural cultures or neurospheres with control
exosomes or media alone to assay synapses and synchronized firing. (B–D)
Control exosomes increased synapse density in MECP2LOF iPSC-derived
neural cultures. Cultures were fixed on DIV 50 and labeled with the neuro-
nal antibody MAP2 and Synapsin1 to identify synaptic puncta. Synaptic
puncta density and intensity were quantified. Images of MAP2 (red) and
Synapsin1 (green) labeling in MECP2LOF neural cultures without exosome
treatment (B) or with control exosome treatment (C). (D) Exosome treat-
ments increased synapse density. Treatment with control exosomes (0.25×
dose) increased presynaptic puncta density to 1.22× ± 0.05 of control (no
exosome) values (P = 0.006, n = 4 wells each, 2-way ANOVA with Bonferroni
correction). (E) Kolmogorov–Smirnoff plot of cumulative frequency of syn-
aptic puncta intensity shows that control exosome treatments (1× control
[red line, D-stat = 0.24, P < 0.0001] and 0.25× control [green line, D-stat =
0.21, P < 0.0001]) increase the fraction of low-intensity puncta compared
with no exosome treatment (blue line). (F–I) Treatment of MECP2LOF
neurospheres with control exosomes increased neural circuit activity. MECP2LOF
hiPSC-derived neurospheres were plated on 64-channel multielectrode array
(MEA; F) and treated with MECP2LOF exosomes or control exosomes. (G)
Graph showing that synchronized bursts of activity occur with a greater
frequency in MECP2LOF neurospheres treated with isogenic control exosomes
compared with neurospheres treated with MECP2LOF exosomes (MECP2LOF
exo, 0.33± 0.33 bursts per 3min; control exo, 2.0 ± 0.68 bursts per 3min; P = 0.03,
n = 3 arrays each, 2-tailed t test). (H and I) Aligned raster plots of spik-
ing activity over 3 min of recordings from active channels. MECP2LOF
neurospheres treated with isogenic control exosomes (I) have more overall
activity and more synchronized activity across different electrodes com-
pared with neurospheres treated with MECP2LOF exosomes (H). Note also
the fewer active channels in neurospheres treated with MECP2LOF exosomes.
(Scale bars: B and C, 50 μm; F, 100 μm.)
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Exosomes were used for assays immediately after purification, as we observed
decreased bioactivity when exosomes were stored overnight at 4 °C. Exosome
collection was consistently started at week 4 from identically and simultaneously
plated isoCONTROL and MECP2LOF neural cultures. Purified exosomes were
added to recipient cultures every 2 d as described in the figures. The protein
content of 1× control exosomes was 0.190 ± 0.031 mg/mL, and that of 1×
MECP2LOF was 0.184 ± 0.033 mg/mL. This is 500× enriched from conditioned
media. Comparable amounts of exosomes were added at each time point. There
was no statistical difference in exosome yield from healthy differentiated neural
cultures from week 4 to week 6. The exosome preparation for proteomics was
prepared in a similar way from 2-d media from 4- to 6-wk-old neural cultures.
Proteomic Analysis. Twelve exosome preparations, half from MECP2LOF iPSC-
derived neural cultures and half from isogenic control iPSC-derived neural
cultures, were labeled with TMT isobaric tags for quantitative mass spec-
trometry (MS) analysis. Two independent MS experiments were performed,
each with 3 different MECP2LOF preparations and 3 different control
preparations obtained from at least 3 independent batches of neuronal
differentiations of NPCs for each line; therefore, 6 biological replicates were
analyzed together in each MS experiment. The TMT labeling was performed
according to the manufacturer’s instructions (Thermo Fisher Scientific) with
modifications as previously described (35). Before loading on a MudPIT
trapping column, the labeled peptide mixture was diluted 5 times with
buffer A (5% acetonitrile/0.1% formic acid) and then centrifuged at 12,000 × g
for 30 min to remove particulates.
LC-MS/MS analysis was performed on an LTQ Orbitrap Velos instrument
(Thermo Scientific) interfaced at the front end with a quaternary HP
1100 series HPLC pump (Agilent Technology) using an in-house–built elec-
trospray stage. The SEQUEST search and DTASelect analysis were performed
identically as previously described (35). To confirm the TMT labeling effi-
ciency, the spectra were also searched without these modifications. Census,
a software tool for quantitative proteomic analysis (36), was used to extract
the relative intensities of reporter ions for each peptide from the
MS2 spectra. Analysis of TMT quantification datasets with Census was per-
formed as previously described (35).
Ingenuity Pathway Analysis software version 01–08 (QIAGEN Bio-
informatics) was used for annotations and pathway analyses. PANTHER
Overrepresentation Test (release 20170413) was performed by using GO
Ontology database (released 4/24/2017) using Homo Sapiens database as a
reference list and GO biological processes complete as an annotation data-
set. Bonferroni correction for multiple testing was applied for statistics.
Exosome/EdU Treatments. Purified control or MECP2LOF exosomes were
resuspended in fresh serum-free growth media and added to lentivirus-
infected human primary neural cultures or iPSC-derived neural cultures by
completely replacing the media. For neurospheres, the exosomes were
resuspended as 10× concentrated stock of doses and added onto neuro-
sphere cultures without replacing media to achieve desired dose concen-
tration. Exosome treatments were performed every second day 2 to 4 times
as described in the schematics in the figures. For EdU labeling experiments,
human primary neural cultures were treated with control or MECP2LOF
exosomes on DIV 5 and 7. On day 7, a 2-h pulse of 10 μM EdU (Thermo Fisher
Scientific) was provided before addition of exosomes. The 1× exosome was
equivalent to 0.19 ± 0.03 mg/mL of protein content.
Generation of Neurospheres. To generate functional neural networks,
growing NPCs were dissociated with Accutase and plated on 6-well dishes (3–
5 × 106 cell per well) under shaker agitation (95 rpm) at 37 °C. The media
used was DMEM-F12 supplemented with 0.5× GEM21 (Gemini), 0.5× N2
(Gemini), and 20 ng/mL bFGF (Life Technologies). The next day (day 0),
neural fate was induced by removing bFGFs and adding 10 μM Rock inhibitor
Y-27632 (Tocris). Two days later (day 2), media was changed to fresh media
without Rock inhibitor. The differentiation took place for 2 wk in suspen-
sion, with media changed every 4 d. On day 15 of differentiation, 3D neu-
rospheres were plated on poly-ornithine/Laminin–precoated 12-well multielectrode
array (MEA) plates (Axion) with DMEM-F12 media supplemented with 0.5×
GEM21, 0.5× N2, and 1% FBS. Media was changed every 3 to 4 d. After 1 to
2 wk, media was replaced with Neurobasal media (Life Technologies)
supplemented with 1× B-27 (Life Technologies) and 1:400 GlutaMAX (Life
Technologies) and changed every 3 to 4 d. Experiments were performed
after 4 to 5 media changes in serum-free medium.
Multielectrode Array Recordings. Spontaneous action potential activity was
recorded by using Axion Biosystems. Purified MECP2LOF or control exosomes
were resuspended in serum-free neurosphere media and were added directly
to MECP2LOF or control neurospheres that had been plated on the multi-
electrode arrays (MEAs). MEA activity in neurospheres without added
exosomes is stable (26). Exosomeswere added every second day to neurospheres
for 1 to 2 wk. Neurosphere activity was recorded before and 24 h after each
exosome addition. MEA channels with similar number and density of cells,
and with more than 10 spikes in a 5-min interval were included in the
analysis. Recordings were analyzed with the software Neuroexplorer (Nex
Technologies) and MATLAB-based Neural Metric Tool Software Axis (Axion
Biosystems). Raster plots were generated using Neuroexplorer.
Immunolabeling, Microscopy, and Image Analysis of Human Cultures. After
treatments, cultures were fixed in 4% paraformaldehyde at room temper-
ature (RT) for 15 min and then permeabilized with 0.5% Triton X-100 in D-PBS
solution with Ca2+ and Mg2+ at RT for 5 min. Cells were then blocked in 5%
normal goat serum in D-PBS solution with Ca2+ and Mg2+ at RT for 1 h before
incubation with primary antibody diluted in 5% normal goat serum over-
night at 4 °C. After 3 washes with D-PBS solution containing Ca2+ and Mg2+,
cells were incubated with Alexa 488, Alexa 568, or Alexa 633 goat anti-
mouse IgG, goat anti-rabbit IgG, or goat anti-chicken IgY (depending on
host for primary antibodies as listed in the SI Appendix) and (H+L) highly
cross-adsorbed secondary antibodies (Invitrogen/Thermo Fisher), followed
by 3 washes with D-PBS solution containing Ca2+ and Mg2+. During the last
wash, the cultures were labeled with DAPI solution (3 ng/mL) for 10 min and
mounted in Prolong Gold mounting media (Invitrogen/Thermo Fisher). Each
experimental condition was blinded before imaging. Imaging was per-
formed with Plan Apo 20× objective with 0.75 NA on a Zeiss LSM 710 or
Nikon A1 confocal system with an Andor iXon EMCCD camera system. Im-
ages were collected from randomized areas in each dish and analyzed by
using Metamorph software (Molecular Devices). Synaptic puncta analysis
was performed by using a custom ImageJ plugin. A trimming procedure was
applied to isolate and segregate individual puncta based on the inclusion of
pixels with intensities greater than 0.3 of maximal intensity within a unit of
connected pixels having intensity greater than the set threshold. This was
achieved by an iterative procedure using a step size (0.01) for each iteration,
which limits for the number of iterations of the trimming procedure. The
resultant image consists of a background-subtracted image containing a set of
well-defined puncta and provides quantification of net intensity per spot and
total pixel area per spot.
Primary Rat Neuron Culture. Cortices from E18 rat embryos were dissected in
Hank’s buffered salt solution (HBSS) supplemented with Hepes (10 mM) and
glucose (0.66 M; Sigma). Cortices were dissociated in papain (Worthington)
supplemented with DNase I (100 μg/mL; Sigma) for 20 min at 37 °C, washed
3 times, and manually triturated in plating medium supplemented with
DNase. Cells were then plated at 3.5 × 106 cells per 10 cm2 on dishes coated
with poly-D-lysine (1 mg/mL; Sigma) in neurobasal medium supplemented
with 2.5% FBS (Gemini), B27 (1×), L-glutamine (2 mM), and P/S (penicillin 2.5
U/mL/streptomycin 2.5 μg/mL). Unless otherwise indicated, all products were
from Invitrogen. After 1 d in vitro, medium was replaced completely with
serum-free neurobasal medium with B-27 (1×), L-glutamine (2 mM), P/S, and
1 μM FUDR (5-fluorodeoxyuridine), and one half of the medium was then
changed every 5 d.
Exosome Purification from Rodent Cultures. The media was harvested from
DIV9 E18 rat primary neural cultures and centrifuged at 300 × g for 15 min at
4 °C. The supernatant was collected and centrifuged at 2,000 × g for 15 min
at 4 °C in a Beckman tabletop centrifuge. The second supernatant was fur-
ther centrifuged by using a Beckman ultracentrifuge at 10,000 × g for 45 min
at 4 °C. The supernatant was collected and centrifuged at 100,000 × g for 1 h
at 4 °C to pellet exosomes. The exosome pellet was resuspended in 1 mL PBS
solution and divided equally into 2 tubes. The tubes were incubated at 37 °C
for 30 min after 100 μg/mL of Proteinase K was added to one and an equal
volume of PBS solution to the other. The exosomes were then washed twice
with PBS solution (Gibco) at 120,000 × g for 1 h at 4 °C followed by resus-
pension in PBS solution to an effective enrichment of 2,400× compared with
conditioned culture media. Proteinase K treatment depletes exosomes of
proteins (SI Appendix, Fig. S5).
P4 Mice Injections. A litter of P4 mice was divided into 2 groups, and 2 μL of
2,400×-enriched exosomes (∼3 ± 0.75 μg protein) from DIV9 E18 rat neural
cultures were injected into the lateral ventricle (LV) of each cerebral hemi-
sphere. One group was injected with proteinase K-treated exosomes,
whereas the other group was injected with control exosomes. Injections
were carried out manually with 1.0-mm glass needles (World Precision Instru-
ments) pulled with P-97 flaming/brown micropipette puller (Sutter Instruments).
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A glass needle with graduated 1-μL volume marks was attached to the syringe
with a tube. Intracerebroventricular injections were followed by peritoneal in-
jections of EdU (5-ethynyl-2′-deoxyuridine; Lumiprobe) at a dose of 25 mg/kg by
using a Hamilton syringe.
Sectioning and Immunolabeling. Twenty-four hours after exosome and EdU
injections, the brains were dissected and fixed in 4% paraformaldehyde for
24 h at 4 °C. Fixed brains were embedded in 4% low-melting agarose and
sliced into 50-μm sections in sagittal plane by using a vibratome (Leica). EdU
incorporated into proliferating cells was detected by conjugating with Sulfo-
Cyanine3 azide dye (Lumiprobe) by using click chemistry. Briefly, sections
were permeabilized with 0.5% Triton-X 100 for 30 min at room tempera-
ture, and click reaction with Sulfo-Cyanine3 azide was performed for 30 min
with CuSO4 as catalyst and ascorbic acid as reductant for copper following
the protocol provided by Lumiprobe. After click reaction, sections were
washed 5 times with PBS solution for 5 min at room temperature and
blocked in 5% normal goat serum (NGS) followed by immunohistochemistry
(as described). Sections were labeled with anti-nestin antibody (MAB353;
Millipore) and TO-PRO-3 (642/661; T3605; Thermo Fisher Scientific) and
mounted in ProLong Gold Antifade (Thermo Fisher Scientific).
Image Processing. Images were background-subtracted as described; 10×
images were used to anatomically match sections through the GCL of the
dentate gyrus of different animals. In 20× high-resolution images, regions of
interest (ROI) were created around the GCL by using nestin and nuclear la-
beling as a guide. EdU+ cells were counted inside the GCL ROI by using
“Manually Count Objects” dropin of Metamorph image-processing soft-
ware. EdU-positive cells in the polymorphic layer that were adjacent to the
GCL were also included.
Quantification and Statistical Analysis. Statistical analysis was performed by
using Microsoft Excel, Statistics Online Computational Resource (SOCR) of
UCLA (socr.ucla.edu/), and GraphPad Prism 7.03. For statistics, 2-way ANOVA
with Bonferroni correction applied for multiple comparisons or independent-
sample Wilcoxon rank-sum test for pairwise comparisons was performed. P
values are provided in figure legends. For cumulative frequency distribution,
the Kolmogorov–Smirnoff test was performed. D-stat, the absolute maximum
difference between 2 cumulative frequency distribution function, and P values
are provided in figure legends.
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